The CEO of infant formula maker Bubs Australia says that the market dynamics in the US has given the firm the confidence that it will become as significant as China.
Content provided by DSM Nutritional Products | 28-Nov-2023
| White Paper
Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...
Content provided by Valio | 29-Sep-2023
| White Paper
Phospholipids’ beneficial effects on children’s health are well established. Less known is the vast and growing scientific evidence showing how phospholipid...